至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Nitro Reduction-Based RNA Control and Ultrafast Release

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2026-08; 
Yiran Zhao, Senfeng Zhang, Junsong Guo, Tuan-Khoa Kha, Song Chen, Chunyi Hu, Ru-Yi Zhu
Products/Services Used Details Operation
Synthetic Guide RNA shRNA was designed from siRNA-targeting regions, analyzed with GPP Web Portal (Broad Institute) and purchased from Genscript Biotech. Get A Quote

摘要

RNA protection and controlled release are critical for both fundamental research and therapeutic applications, yet the development of simple, efficient, and reversible post-synthetic RNA modification strategies remains a significant challenge. Here, we introduce a straightforward approach based on ribose 2'-hydroxyl acylation with a nitro-functionalized carbamate, which acts as a redox-responsive center. This modification selectively inhibits native RNA function while remaining inert to endogenous biogenic reductants and common reducing agents used in biological assays. Upon treatment with low millimolar concentrations of the diboron-bipyridine reducing pair, RNA function is rapidly restored on a minute timesca... More

关键词

RNA caging; nitro reduction; post‐synthetic modification